Tropomyosin Receptor Kinases Inhibitors [MoA] - N0000193859

Pharmacologic Class Information

Pharmacologic Code N0000193859
Pharmacologic Name Tropomyosin Receptor Kinases Inhibitors
Pharmacologic Uses
  • kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Tropomyosin Receptor Kinases Inhibitors

The following table contains 6 products whose active ingredient are classified under the same pharmacologic class Tropomyosin Receptor Kinases Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50419-390Vitrakvi Non-Proprietary Name: LarotrectinibCapsuleOralBayer Healthcare Pharmaceuticals Inc.ACTIVE
50419-391Vitrakvi Non-Proprietary Name: LarotrectinibCapsuleOralBayer Healthcare Pharmaceuticals Inc.ACTIVE
50419-392Vitrakvi Non-Proprietary Name: LarotrectinibSolution, ConcentrateOropharyngealBayer Healthcare Pharmaceuticals Inc.ACTIVE
71777-390Vitrakvi Non-Proprietary Name: LarotrectinibCapsuleOralLoxo Oncology, Inc.ACTIVE
71777-391Vitrakvi Non-Proprietary Name: LarotrectinibCapsuleOralLoxo Oncology, Inc.ACTIVE
71777-392Vitrakvi Non-Proprietary Name: LarotrectinibSolutionOralLoxo Oncology, Inc.ACTIVE